// App-Quantinova.ai

207P : BIOMARKER ANALYSES OF A PHASE I/II STUDY OF NANOPARTICLE ALBUMIN-BOUND PACLITAXEL PLUS CISPLATIN IN THE TREATMENT OF ADVANCED NASOPHARYNGEAL CARCINOMAS

Researchers

Presenter

  • W. Liang

Principal Investigators

  • L. Zhao

  • X. Wu

  • Y. Huang

  • H. Zhao

  • Z. Li

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Nasopharyngeal carcinoma

  • Breast cancer

  • Solid malignancies

Biomarkers

  • ATP Binding Cassette Transporter B1

  • Breast cancer type 1 susceptibility protein

  • Osteonectin

  • Circulating tumor cells

  • Excision repair cross-complementation group 1

Drug/Treatment

  • Protein-bound paclitaxel

  • Cisplatin

  • Cysteine Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved